Anzeige
Mehr »
Freitag, 03.07.2026 - Börsentäglich über 12.000 News
Neben Europas Lithium-Gigant: Hebt dieser 8,8-Mio.-Nanocap jetzt ebenfalls ab?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JCLB | ISIN: FR0011049824 | Ticker-Symbol: 4ZG
Stuttgart
03.07.26 | 09:07
5,300 Euro
+7,61 % +0,375
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
MEDIAN TECHNOLOGIES Chart 1 Jahr
5-Tage-Chart
MEDIAN TECHNOLOGIES 5-Tage-Chart
RealtimeGeldBriefZeit
5,1005,14009:29
5,1005,14009:29

Aktuelle News zur MEDIAN TECHNOLOGIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
07:06Median Technologies' eyonis LCS Obtains CE Marking274European marketing authorization follows U.S. FDA clearance of eyonis LCS, Median's AI-based Software as a Medical Device designed to aid in the detection and diagnosis of lung cancer in screening...
► Artikel lesen
08.06.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of May 31, 2026287Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
03.06.Median Technologies Announces Successful Upsized Capital Increase of € 50 Million761Not to be published, distributed or disseminated, directly or indirectly, in the United States of America, Australia, Canada, South Africa and Japan Great Success of the capital increase with...
► Artikel lesen
01.06.Median Technologies Brings Forward Subscription Period of its €50 Million Capital Increase on the Back of Strong Demand from Institutional Investors458The €50 million capital increase, with a subscription price of €5.00 per New Share launched on May 27, 2026, is already oversubscribed The Public Offering period, initially scheduled to...
► Artikel lesen
28.05.Median Technologies: €40 Million Capital Increase Launched To Support eyonis LCS Expansion1
27.05.Median Technologies Launches a Capital Increase of €40 million, with Potential Upsize to €50 million, to Support the Deployment of eyonis LCS in the U.S. and Europe and Advance New Clinical Indications for Its Proprietary eyonis...1.225Share capital increase without shareholders' preferential subscription rights, to be carried out by way of an issue of ordinary shares in the framework of a public offering, for an amount of approximately...
► Artikel lesen
26.05.Median Technologies to Showcase iCRO's Central and AI-powered Imaging Services for Oncology Clinical Trials at ASCO 2026277Median is a leading provider of imaging services to the world's top oncology pharma companies Median will host two presentation sessions to introduce its new solutions for radiopharmaceutical...
► Artikel lesen
MEDIAN TECHNOLOGIES Aktie jetzt für 0€ handeln
21.05.Median Technologies Announces the Availability of the Preparatory Documents for the Annual Shareholders' Ordinary and Extraordinary General Meeting on June 10, 2026529Regulatory News: The shareholders of Median Technologies (FR0011049824, ALMDT, "Median" or "The Company") are invited to participate in the Annual Shareholders' Ordinary and Extraordinary General...
► Artikel lesen
04.05.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of April 30, 2026308Pursuant to article L-223-8 II of the French "Code de commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
23.04.Median Technologies Reports Full-Year 2025 Financial Results and Provides Key Q1 2026 Business Highlights775eyonis LCS 510(k) clearance sets stage for commercialization in the United States New leadership of U.S. subsidiary and collaboration with Tempus accelerate rollout 28% reduction...
► Artikel lesen
07.04.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of March 31, 2026384Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
18.03.Median Technologies Achieves ISO 13485:2016 Certification for eyonis Medical Device Quality Management System658Certification of a robust and compliant Quality Management System for AI-based Software as Medical Devices, as per internationally recognized medical device regulatory standards Pledge...
► Artikel lesen
13.03.Median Technologies Meets the Eligibility Conditions for the PEA-PME Scheme476Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company"), developer of eyonis, a suite of artificial intelligence (AI) powered Software as...
► Artikel lesen
09.03.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of February 28, 2026354Pursuant to article L-223-8 II of the French "Code de commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
02.03.Median Technologies to Showcase eyonis LCS, Its AI/ML-based Software as a Medical Device for Lung Cancer Screening, at the European Congress of Radiology481eyonis LCS commercial launch is ongoing in U.S. following FDA 510(k) clearance CE-marking regulatory process is on-going with a decision expected in Q2 2026 that could trigger commercial...
► Artikel lesen
27.02.Median Technologies to present at the TD Cowen 46th Annual Health Care Conference429Regulatory News: Median Technologies (FR0011049824, ALMDT, "Median" or the "Company"), developer of eyonis, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for...
► Artikel lesen
23.02.Median Technologies to Host Webcasts Highlighting Strategic Advances Driving U.S. Deployment of eyonis LCS350Webcasts on February 26, 2026, at 5:45 pm CET (held in French): sign-up link and 6:45 pm CET/12:45 pm ET (held in English): sign-up link Regulatory News: Median Technologies (FR0011049824, ALMDT...
► Artikel lesen
18.02.Median Technologies: FDA Clearance Sets Stage for U.S. Commercialization of eyonis LCS Software as a Medical Device for Lung Cancer Screening; Oran Muduroglu Appointed President of Median eyonis Inc.665Oran Muduroglu, proven medical imaging entrepreneur, to lead U.S. launch of eyonis LCS Established U.S. commercial and clinical infrastructure combined with Medicare reimbursement pathway...
► Artikel lesen
12.02.Median Technologies Announces Collaboration With Tempus to Expand Access to eyonis LCS Software as a Medical Device in the United States513The collaboration follows FDA 510(k) clearance for eyonis LCS and aims to integrate high-performance lung cancer screening detection and diagnosis device into the clinical workflow through the Tempus...
► Artikel lesen
11.02.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of January 31, 2026416Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
Weiter >>
44 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1